W01 Waiver of COVID-19 vaccine patents新冠疫苗知识产权豁免
【例句】A major decision on the waiver of intellectual property rights for COVID-19 vaccines was made at the World Trade Organization’s Ministerial Conference Twelfth Session(MC12)from June 12 to 17,2022 in Geneva,Switzerland.At a pivotal stage of MC12 negotiations,China,as a major producer and a supplier of COVID-19 vaccines,announced that it will forego the flexibility of the Trade-Related Aspects of Intellectual Property Rights waiver on COVID-19 vaccines,which shows China’s sense of responsibility as a major country,an official with the Ministry of Commerce said.(https://language.chinadaily.com.cn/a/202206/22/WS62b2da1ba310fd2b29e67ebd.html)
【译文】2022年6月12日至17日,在瑞士日内瓦举行的世界贸易组织第12届部长级会议就新冠疫苗知识产权豁免达成部长决定。商务部称,在会议谈判的关键阶段,作为新冠疫苗生产和供应大国,中国主动宣布不寻求享受豁免决定所提供的灵活性,彰显了大国担当。(https://www.daowen.com)
【练习】China has made important contributions to the waiver of COVID-19 vaccine patents and played a constructive role in the crucial moments of the negotiations。